Ultrasound-guided percutaneous biopsy demonstrates high diagnostic accuracy in thoracic lesions, indicating low adverse events for extrapulmonary targets.
US-guided percutaneous core biopsy has a high diagnostic accuracy and low complication rate. However, safety varies according to site, with serious adverse events limited to patients with lung parenchymal targets. US-guided core biopsy is a feasible first-line approach for accessible extrapulmonary thoracic lesions; however, careful consideration is required for intrapulmonary targets.
No takes yet. Share an insight, caveat, or question.
Sogabe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: